Share Close
Select Where You Want To Share:
Go Ahead and Share This Blog and Watch The Views Soar!
Shared Blogs Receive 98% More Views!
Share On SB Share this on Facebook Share this on Twitter Share this on LinkedIn Share this on Digg Share this on Tumblr Share this on Reddit Blog This on Blogger Share this on Pinterest
Minimal Residual Disease Testing Market: A $2.3 Billion Projection by 2027
https://www.storeboard.com/blogs/business/minimal-residual-disease-testing-market-a-$23-billion-projection-by-2027/5726371  
Copy
The global minimal residual disease testing market in terms of revenue was estimated to be worth $1.2 billion in 2022 and is poised to reach $2.3 billion by 2027, growing at a CAGR of 14.0% from 2022 to 2027.